BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 28404961)

  • 1. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
    Tan D; Fu Y; Su Q; Wang H
    Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
    You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
    Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
    Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
    Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
    Gu X; Gao XS; Qin S; Li X; Qi X; Ma M; Yu H; Sun S; Zhou D; Wang W; Xiong W
    PLoS One; 2016; 11(9):e0163523. PubMed ID: 27658306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.
    Zhu Y; Si W; Sun Q; Qin B; Zhao W; Yang J
    Oncotarget; 2017 Jan; 8(1):1023-1030. PubMed ID: 27906679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
    Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
    Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
    Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
    [No Abstract]   [Full Text] [Related]  

  • 12. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
    Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
    Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.
    Wei Y; Zhang X; Wang G; Zhou Y; Luo M; Wang S; Hong C
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e243-e251. PubMed ID: 29532611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of platelet-to-lymphocyte ratio on prognosis in patients with colorectal cancer: A systematic review and meta-analysis.
    Guo G; Hu X; Gao T; Zhou H; Li B; Zhou C; Yu B; Wang G
    Front Surg; 2023; 10():1139503. PubMed ID: 37051571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
    Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma.
    Demirci NS; Ozdemir NY; Erdem GU; Bozkaya Y; Yazici O; Zengin N
    Bratisl Lek Listy; 2018; 119(3):180-186. PubMed ID: 29536748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.